John A. Ormiston

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

Patrick W. Serruys, John A. Ormiston, Yoshinobu Onuma et al. · The Lancet · 2009 · 816 citations

Percutaneous Coronary Intervention, Cardiovascular Translational Research, Cardiovascular Disease +10

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

John A. Ormiston, Patrick W. Serruys, Evelyn Regar et al. · The Lancet · 2008 · 714 citations

Percutaneous Coronary Intervention, Prospective Open-label Trial, Cardiovascular Disease +6

Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction

Harvey D. White, R M Norris, Michael Brown et al. · New England Journal of Medicine · 1987 · 620 citations

Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis

Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek et al. · Journal of the American College of Cardiology · 2011 · 525 citations

Tissue Engineering, Percutaneous Coronary Intervention, Engineering +11

Size and motion of the mitral valve annulus in man. I. A two-dimensional echocardiographic method and findings in normal subjects.

John A. Ormiston, Pravin M. Shah, Chuwa Tei et al. · Circulation · 1981 · 461 citations

Heart Failure, Mitral Annular Reconstruction, Surgery +18